Science News
Science News coverage from Reuters.
Roche's Tecentriq plus chemotherapy boosted lung cancer patients' survival by nearly five months, study data released on Monday showed, underscoring benefits of the Swiss group's immunotherapy but still leaving it trailing a rival's drug.
German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.
Roche's entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.
An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation.
An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.
A European-Japanese spacecraft set off on a treacherous seven-year journey to Mercury to probe the solar system's smallest and least-explored planet.
Crunchy and tasty, yes, but could carrots also strengthen cement and cut carbon dioxide emissions for the building industry?
The skull of Luzia, the oldest known human fossil in the Americas, was found by researchers combing through debris at Brazil's National Museum, which burned down in September, the Museum said on Friday.
For the first time, humans will visit the deepest part of each of the five oceans, plunging to the sea floor using a two-person craft designed to withstand the intense pressures more than 5.5 miles (9 km) below the surface.
Astronomers peering billions of light years into space have detected the largest, most extensive collection of galaxies ever registered in the early days of the universe, a "proto-supercluster" they nicknamed Hyperion after a titan from Greek mythology.
U.S. regulators have cleared the way for farmers to grow a cotton plant genetically modified to make the cottonseed edible for people, a protein-packed potential new food source that could be especially useful in cotton-growing countries beset with malnutrition.
A respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients.
Russian cosmonaut Alexei Ovchinin shrugged off on Tuesday his emergency landing last week, saying there had been no time to worry as his capsule plunged back to earth.
The crew aboard the International Space Station (ISS) has enough fuel, oxygen, water, and food to last at least six months, Vladimir Solovyov, flight director of the Russian segment of the ISS, was cited as saying by Russian news agencies on Sunday.
The next manned flight of a Soyuz rocket to the International Space Station (ISS) could take place on Nov. 28, Interfax news agency quoted a Russian space industry source on Saturday as saying.
Two astronauts who survived the mid-air failure of a Russian rocket will fly again and are provisionally set to travel to the International Space Station (ISS) in spring of next year, the head of Russia's space agency said on Friday.
British billionaire Richard Branson said on Thursday that his Virgin Group would suspend its discussions with Saudi Arabia's Public Investment Fund over a planned $1 billion investment in the group's space ventures, in light of the disappearance of Saudi journalist Jamal Khashoggi.
NASA administrator Jim Bridenstine said on Friday that he had full confidence in the U.S.-Russian space relationship, but that a rocket failure this week showed the importance of having more than one way of getting people into space.
Roche's Tecentriq plus chemotherapy boosted lung cancer patients' survival by nearly five months, study data released on Monday showed, underscoring benefits of the Swiss group's immunotherapy but still leaving it trailing a rival's drug.
German drugmaker Merck KGaA might agree partnership deals to jointly develop two of its most promising experimental medicines with a rival as early as this year, but more likely in 2019, its drug research and development chief said on Sunday.
An AstraZeneca drug that blocks a cancer cell's ability to repair its genetic code greatly reduced the risk of ovarian cancer worsening in a phase III trial, underpinning its lead against two U.S. rivals in the same class.
Roche's entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.
An experimental cancer drug that Novartis hopes will raise the profile of its oncology portfolio cut the risk of death or disease progression by more than a third in breast cancer patients with a hard-to-target gene mutation.
An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments have proven elusive, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.
A European-Japanese spacecraft set off on a treacherous seven-year journey to Mercury to probe the solar system's smallest and least-explored planet.
Crunchy and tasty, yes, but could carrots also strengthen cement and cut carbon dioxide emissions for the building industry?
The skull of Luzia, the oldest known human fossil in the Americas, was found by researchers combing through debris at Brazil's National Museum, which burned down in September, the Museum said on Friday.
For the first time, humans will visit the deepest part of each of the five oceans, plunging to the sea floor using a two-person craft designed to withstand the intense pressures more than 5.5 miles (9 km) below the surface.
Astronomers peering billions of light years into space have detected the largest, most extensive collection of galaxies ever registered in the early days of the universe, a "proto-supercluster" they nicknamed Hyperion after a titan from Greek mythology.
U.S. regulators have cleared the way for farmers to grow a cotton plant genetically modified to make the cottonseed edible for people, a protein-packed potential new food source that could be especially useful in cotton-growing countries beset with malnutrition.
A respected science journal is to withdraw a much-cited review of evidence on an illness known as chronic fatigue syndrome (CFS) amid fierce criticism and pressure from activists and patients.
Russian cosmonaut Alexei Ovchinin shrugged off on Tuesday his emergency landing last week, saying there had been no time to worry as his capsule plunged back to earth.
The crew aboard the International Space Station (ISS) has enough fuel, oxygen, water, and food to last at least six months, Vladimir Solovyov, flight director of the Russian segment of the ISS, was cited as saying by Russian news agencies on Sunday.
The next manned flight of a Soyuz rocket to the International Space Station (ISS) could take place on Nov. 28, Interfax news agency quoted a Russian space industry source on Saturday as saying.
Two astronauts who survived the mid-air failure of a Russian rocket will fly again and are provisionally set to travel to the International Space Station (ISS) in spring of next year, the head of Russia's space agency said on Friday.
British billionaire Richard Branson said on Thursday that his Virgin Group would suspend its discussions with Saudi Arabia's Public Investment Fund over a planned $1 billion investment in the group's space ventures, in light of the disappearance of Saudi journalist Jamal Khashoggi.
NASA administrator Jim Bridenstine said on Friday that he had full confidence in the U.S.-Russian space relationship, but that a rocket failure this week showed the importance of having more than one way of getting people into space.
- narrow-browser-and-phone
- medium-browser-and-portrait-tablet
- landscape-tablet
- medium-wide-browser
- wide-browser-and-larger
- medium-browser-and-landscape-tablet
- medium-wide-browser-and-larger
- above-phone
- portrait-tablet-and-above
- above-portrait-tablet
- landscape-tablet-and-above
- landscape-tablet-and-medium-wide-browser
- portrait-tablet-and-below
- landscape-tablet-and-below